Skip to main content
OpenTrials
Completed

NCT Number: NCT02601352

Air Pollution and Cardiometabolic Study

The study mainly focuse on examining the subjects living in traffic polluted area and assessing the popuation health risk using disease and risk assessment models.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiovascular Outcomes

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Peking University, Beijing, Beijing Municipality, China

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Living in PU community neighborhood，Non smoker and No diseases ,and so on.

Exclusion criteria

  • Advanced microvascular or neuropathic complications and active cardiovascular disease,and so on.

Treatment and study plan

Primary outcomes

  1. Vascular endothelial function

    Time frame: Four months

    Vascular endothelial function measured by Endo-PAT2000

  2. Arrythmias

    Time frame: Four months

    Twenty four-hour electrocardiograms

Secondary outcomes

  1. System inflammatory

    Time frame: Four months

    Analyzed systemic inflammation biomarkers,such as C-reaction Protein and Blood coagulation by ELISA

Sponsors and collaborators

Lead sponsor

WeiHuang

Other

Registry information

Official study title

Characterization and Health Risk Assessment of Exposure to Source-Specific PM2.5 in Subjects in Beijing

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Nov 10, 2015
Registry last updated
Apr 5, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.